The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostic Biomarker Market Research Report 2025
Synopsis
Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
The global Diagnostic Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarker.
Report Scope
The Diagnostic Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela
Segment by Type
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
The global Diagnostic Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Biomarker.
Report Scope
The Diagnostic Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela
Segment by Type
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others
Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnostic Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 S100
1.2.3 MART-1
1.2.4 Gp100
1.2.5 HMB45
1.2.6 AFP
1.2.7 BCR-ABL
1.2.8 Others
1.3 Market by Application
1.3.1 Global Diagnostic Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Biomarker Market Perspective (2019-2030)
2.2 Diagnostic Biomarker Growth Trends by Region
2.2.1 Global Diagnostic Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diagnostic Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Diagnostic Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Diagnostic Biomarker Market Dynamics
2.3.1 Diagnostic Biomarker Industry Trends
2.3.2 Diagnostic Biomarker Market Drivers
2.3.3 Diagnostic Biomarker Market Challenges
2.3.4 Diagnostic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Biomarker Players by Revenue
3.1.1 Global Top Diagnostic Biomarker Players by Revenue (2019-2024)
3.1.2 Global Diagnostic Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Diagnostic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Biomarker Revenue
3.4 Global Diagnostic Biomarker Market Concentration Ratio
3.4.1 Global Diagnostic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarker Revenue in 2023
3.5 Diagnostic Biomarker Key Players Head office and Area Served
3.6 Key Players Diagnostic Biomarker Product Solution and Service
3.7 Date of Enter into Diagnostic Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Biomarker Breakdown Data by Type
4.1 Global Diagnostic Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Diagnostic Biomarker Forecasted Market Size by Type (2025-2030)
5 Diagnostic Biomarker Breakdown Data by Application
5.1 Global Diagnostic Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Diagnostic Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diagnostic Biomarker Market Size (2019-2030)
6.2 North America Diagnostic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diagnostic Biomarker Market Size by Country (2019-2024)
6.4 North America Diagnostic Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnostic Biomarker Market Size (2019-2030)
7.2 Europe Diagnostic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diagnostic Biomarker Market Size by Country (2019-2024)
7.4 Europe Diagnostic Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Diagnostic Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diagnostic Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Diagnostic Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnostic Biomarker Market Size (2019-2030)
9.2 Latin America Diagnostic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diagnostic Biomarker Market Size by Country (2019-2024)
9.4 Latin America Diagnostic Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Diagnostic Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diagnostic Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Diagnostic Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Detail
11.1.2 Biocrates Life Sciences Business Overview
11.1.3 Biocrates Life Sciences Diagnostic Biomarker Introduction
11.1.4 Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2019-2024)
11.1.5 Biocrates Life Sciences Recent Development
11.2 Augurex Life Sciences
11.2.1 Augurex Life Sciences Company Detail
11.2.2 Augurex Life Sciences Business Overview
11.2.3 Augurex Life Sciences Diagnostic Biomarker Introduction
11.2.4 Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2019-2024)
11.2.5 Augurex Life Sciences Recent Development
11.3 Biomedical
11.3.1 Biomedical Company Detail
11.3.2 Biomedical Business Overview
11.3.3 Biomedical Diagnostic Biomarker Introduction
11.3.4 Biomedical Revenue in Diagnostic Biomarker Business (2019-2024)
11.3.5 Biomedical Recent Development
11.4 Target Discovery
11.4.1 Target Discovery Company Detail
11.4.2 Target Discovery Business Overview
11.4.3 Target Discovery Diagnostic Biomarker Introduction
11.4.4 Target Discovery Revenue in Diagnostic Biomarker Business (2019-2024)
11.4.5 Target Discovery Recent Development
11.5 Banyan Biomarkers
11.5.1 Banyan Biomarkers Company Detail
11.5.2 Banyan Biomarkers Business Overview
11.5.3 Banyan Biomarkers Diagnostic Biomarker Introduction
11.5.4 Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2019-2024)
11.5.5 Banyan Biomarkers Recent Development
11.6 Astute Medical
11.6.1 Astute Medical Company Detail
11.6.2 Astute Medical Business Overview
11.6.3 Astute Medical Diagnostic Biomarker Introduction
11.6.4 Astute Medical Revenue in Diagnostic Biomarker Business (2019-2024)
11.6.5 Astute Medical Recent Development
11.7 Axela
11.7.1 Axela Company Detail
11.7.2 Axela Business Overview
11.7.3 Axela Diagnostic Biomarker Introduction
11.7.4 Axela Revenue in Diagnostic Biomarker Business (2019-2024)
11.7.5 Axela Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Diagnostic Biomarker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of S100
Table 3. Key Players of MART-1
Table 4. Key Players of Gp100
Table 5. Key Players of HMB45
Table 6. Key Players of AFP
Table 7. Key Players of BCR-ABL
Table 8. Key Players of Others
Table 9. Global Diagnostic Biomarker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Diagnostic Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Diagnostic Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Diagnostic Biomarker Market Share by Region (2019-2024)
Table 13. Global Diagnostic Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Diagnostic Biomarker Market Share by Region (2025-2030)
Table 15. Diagnostic Biomarker Market Trends
Table 16. Diagnostic Biomarker Market Drivers
Table 17. Diagnostic Biomarker Market Challenges
Table 18. Diagnostic Biomarker Market Restraints
Table 19. Global Diagnostic Biomarker Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Diagnostic Biomarker Market Share by Players (2019-2024)
Table 21. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarker as of 2023)
Table 22. Ranking of Global Top Diagnostic Biomarker Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Diagnostic Biomarker Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Diagnostic Biomarker Product Solution and Service
Table 26. Date of Enter into Diagnostic Biomarker Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Diagnostic Biomarker Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Diagnostic Biomarker Revenue Market Share by Type (2019-2024)
Table 30. Global Diagnostic Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Diagnostic Biomarker Revenue Market Share by Type (2025-2030)
Table 32. Global Diagnostic Biomarker Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Diagnostic Biomarker Revenue Market Share by Application (2019-2024)
Table 34. Global Diagnostic Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Diagnostic Biomarker Revenue Market Share by Application (2025-2030)
Table 36. North America Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Diagnostic Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Diagnostic Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Diagnostic Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Diagnostic Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Diagnostic Biomarker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Diagnostic Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Diagnostic Biomarker Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Diagnostic Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Diagnostic Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Diagnostic Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Diagnostic Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Diagnostic Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 51. Biocrates Life Sciences Company Detail
Table 52. Biocrates Life Sciences Business Overview
Table 53. Biocrates Life Sciences Diagnostic Biomarker Product
Table 54. Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 55. Biocrates Life Sciences Recent Development
Table 56. Augurex Life Sciences Company Detail
Table 57. Augurex Life Sciences Business Overview
Table 58. Augurex Life Sciences Diagnostic Biomarker Product
Table 59. Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 60. Augurex Life Sciences Recent Development
Table 61. Biomedical Company Detail
Table 62. Biomedical Business Overview
Table 63. Biomedical Diagnostic Biomarker Product
Table 64. Biomedical Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 65. Biomedical Recent Development
Table 66. Target Discovery Company Detail
Table 67. Target Discovery Business Overview
Table 68. Target Discovery Diagnostic Biomarker Product
Table 69. Target Discovery Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 70. Target Discovery Recent Development
Table 71. Banyan Biomarkers Company Detail
Table 72. Banyan Biomarkers Business Overview
Table 73. Banyan Biomarkers Diagnostic Biomarker Product
Table 74. Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 75. Banyan Biomarkers Recent Development
Table 76. Astute Medical Company Detail
Table 77. Astute Medical Business Overview
Table 78. Astute Medical Diagnostic Biomarker Product
Table 79. Astute Medical Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 80. Astute Medical Recent Development
Table 81. Axela Company Detail
Table 82. Axela Business Overview
Table 83. Axela Diagnostic Biomarker Product
Table 84. Axela Revenue in Diagnostic Biomarker Business (2019-2024) & (US$ Million)
Table 85. Axela Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Biomarker Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diagnostic Biomarker Market Share by Type: 2023 VS 2030
Figure 3. S100 Features
Figure 4. MART-1 Features
Figure 5. Gp100 Features
Figure 6. HMB45 Features
Figure 7. AFP Features
Figure 8. BCR-ABL Features
Figure 9. Others Features
Figure 10. Global Diagnostic Biomarker Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Diagnostic Biomarker Market Share by Application: 2023 VS 2030
Figure 12. Hospitals Case Studies
Figure 13. Cancer Research Institutes Case Studies
Figure 14. Diagnostic Labs Case Studies
Figure 15. Diagnostic Biomarker Report Years Considered
Figure 16. Global Diagnostic Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Diagnostic Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Diagnostic Biomarker Market Share by Region: 2023 VS 2030
Figure 19. Global Diagnostic Biomarker Market Share by Players in 2023
Figure 20. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Biomarker as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Diagnostic Biomarker Revenue in 2023
Figure 22. North America Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Diagnostic Biomarker Market Share by Country (2019-2030)
Figure 24. United States Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Diagnostic Biomarker Market Share by Country (2019-2030)
Figure 28. Germany Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Diagnostic Biomarker Market Share by Region (2019-2030)
Figure 36. China Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Diagnostic Biomarker Market Share by Country (2019-2030)
Figure 44. Mexico Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Diagnostic Biomarker Market Share by Country (2019-2030)
Figure 48. Turkey Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Diagnostic Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Biocrates Life Sciences Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 51. Augurex Life Sciences Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 52. Biomedical Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 53. Target Discovery Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 54. Banyan Biomarkers Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 55. Astute Medical Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 56. Axela Revenue Growth Rate in Diagnostic Biomarker Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
